Marshall Wace
IMUX icon

Marshall Wace’s Immunic IMUX Stock Holding History

Marshall Wace’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
104,816
+9,519
+10% +$117K ﹤0.01% 1965
2026
Q1 		$1.06M Sell
95,297
-6,701
-7% -$60K ﹤0.01% 2110
2025
Q4 		$541K Buy
101,998
+48,646
+91% +$356K ﹤0.01% 2205
2025
Q3 		$469K Buy
53,352
+48,353
+967% +$426K ﹤0.01% 2254
2025
Q2 		$35K Sell
4,999
-51,355
-91% -$471K ﹤0.01% 2618
2025
Q1 		$614K Buy
56,354
+14,566
+35% +$157K ﹤0.01% 1990
2024
Q4 		$418K Sell
41,788
-4,841
-10% -$61K ﹤0.01% 2113
2024
Q3 		$769K Buy
46,629
+42,667
+1,077% +$607K ﹤0.01% 1759
2024
Q2 		$44K Sell
3,962
-991
-20% -$12.3K ﹤0.01% 2452
2024
Q1 		$65.4K Buy
4,953
+3,025
+157% +$39.3K ﹤0.01% 2332
2023
Q4 		$28.9K Sell
1,928
-17,157
-90% -$210K ﹤0.01% 2098
2023
Q3 		$281K Buy
+19,085
New +$367K ﹤0.01% 1906
2023
Q2 		– Sell
-13,446
Closed -$200K – 2687
2023
Q1 		$200K Buy
13,446
+3,697
+38% +$68.6K ﹤0.01% 2411
2022
Q4 		$136K Buy
9,749
+7,312
+300% +$199K ﹤0.01% 2755
2022
Q3 		$77K Buy
+2,437
New +$102K ﹤0.01% 3209
2022
Q1 		– Sell
-243
Closed -$24K – 3643
2021
Q4 		$24K Buy
+243
New +$21.9K ﹤0.01% 3689

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Marshall Wace's IMUX Position: Q2 2026 in Review

Marshall Wace increased its Immunic (IMUX) stake by 10% in Q2 2026, buying an estimated $117K and bringing the position to 104,816 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

Marshall Wace first reported a position in IMUX in Q4 2021 and has held it in 16 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Marshall Wace held 104,816 shares of Immunic worth $1.61M as of Q2 2026.
  • Marshall Wace bought 9,519 Immunic shares in Q2 2026, an estimated $117K.
  • Immunic made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1965 holding.
  • Marshall Wace first reported a position in Immunic in Q4 2021 and has held it in 16 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.